Current status: 832 hESC lines, 3208 hiPSC lines, and 99 clinical studies, and 428 certificates
Monthly statistic from Jul 1, 2022
Posted on July 1, 2022
| total lines | 4040 |
| hESC lines | 832 |
| hiPSC lines | 3208 |
| derivation countries | 43 |
| projects | 237 |
| providers | 734 |
| clinical studies | 99 |
| subclones | 1589 |
| certificates | 428 |
| cell line certificates | 307 |
| project certificates | 121 |